146 related articles for article (PubMed ID: 31210298)
1. Effects of RXRα on proliferation and apoptosis of pancreatic cancer cells through TGF-β/Smad signaling pathway.
Chen G; Hu M; Wang XC; Du SH; Cheng ZX; Xu J; Qu YK
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4723-4729. PubMed ID: 31210298
[TBL] [Abstract][Full Text] [Related]
2. siRNA-Mediated SBF2 Silencing May Inhibit Pancreatic Cancer Cells via Attenuation of the TGF-β Signaling Pathway.
Long J; Liu Z; Wu X; Xu Y; Ge C
Technol Cancer Res Treat; 2016 Apr; 15(2):308-13. PubMed ID: 25882882
[TBL] [Abstract][Full Text] [Related]
3. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
4. Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling.
Jin X; Wu Y
Anat Rec (Hoboken); 2014 May; 297(5):802-9. PubMed ID: 24619961
[TBL] [Abstract][Full Text] [Related]
5. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
Thakur AK; Nigri J; Lac S; Leca J; Bressy C; Berthezene P; Bartholin L; Chan P; Calvo E; Iovanna JL; Vasseur S; Guillaumond F; Tomasini R
Cell Death Differ; 2016 Aug; 23(8):1358-70. PubMed ID: 26943320
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
7. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
[TBL] [Abstract][Full Text] [Related]
8. Effects of lncRNA ANRIL on proliferation and apoptosis of oral squamous cell carcinoma cells by regulating TGF-β/Smad pathway.
Liu L; Ning SB; Fu S; Mao Y; Xiao M; Guo B
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6194-6201. PubMed ID: 31364119
[TBL] [Abstract][Full Text] [Related]
9. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.
Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of ALK1 in pancreatic carcinoma cells.
Ungefroren H; Schniewind B; Groth S; Chen WB; Müerköster SS; Kalthoff H; Fändrich F
Int J Cancer; 2007 Apr; 120(8):1641-51. PubMed ID: 17230504
[TBL] [Abstract][Full Text] [Related]
11. Correlation between S100A11 and the TGF-β
Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
[TBL] [Abstract][Full Text] [Related]
12. Effect of retinoid X receptor-α nuclear export inhibition on apoptosis of neurons in vivo and in vitro.
Liu Y; Tang J; Gao X; Wang M; Shen J; You X
Mol Med Rep; 2017 Aug; 16(2):2037-2044. PubMed ID: 28627642
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
[TBL] [Abstract][Full Text] [Related]
14. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
15. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
17. TFEB-driven autophagy potentiates TGF-β induced migration in pancreatic cancer cells.
He R; Wang M; Zhao C; Shen M; Yu Y; He L; Zhao Y; Chen H; Shi X; Zhou M; Pan S; Liu Y; Guo X; Li X; Qin R
J Exp Clin Cancer Res; 2019 Aug; 38(1):340. PubMed ID: 31387632
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathway.
Qin CF; Zhao FL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2377-2384. PubMed ID: 28617552
[TBL] [Abstract][Full Text] [Related]
19. miR-1306 Mediates the Feedback Regulation of the TGF-β/SMAD Signaling Pathway in Granulosa Cells.
Yang L; Du X; Liu L; Cao Q; Pan Z; Li Q
Cells; 2019 Mar; 8(4):. PubMed ID: 30935128
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
